Growth drivers for Indonesian pharmaceutical market led by government policies

The key drivers for the Indonesian pharmaceutical market are the introduction of 15 economic policy packages to attract foreign investors, the implementation of Universal Health Coverage scheme (Jaminan Kesehatan Nasional, JKN), and growing urban population.

However, inadequate public and private infrastructure, traditional and counterfeit medicines, and poor healthcare spending remain major challenges, according to GlobalData, a leader in providing business information and analytics.

Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN) and is expected to reach $10.11 billion by 2021, says GlobalData.